|  |  |  | YSR Total Problems T-score at T2 | ||||
---|---|---|---|---|---|---|---|---|
Psychiatric disorders T1a | Â | Â | Treatment procedures | Adjusted for age T1 and SES | ||||
 | n | (%) |  | n | % | β | 95% CI | p-value |
Total sample | ||||||||
 Any psychiatric disorder | 447 |  | Psychotherapyb | 299/424 | (70.5) | 0.5 | 0.3 to 0.7 | < 0.001 |
 |  |  | Medicationc | 236/445 | (53.0) | −1.7 | −7.4 to 4.0 | 0.566 |
 Anxiety disorders | 151/447 | (33.8) | Psychotherapy | 95/150 | (63.3) | 0.5 | 0.1 to 0.8 | 0.007 |
 |  |  | Medication | 56/150 | (37.3) | 9.0 | −0.6 to 18.7 | 0.067 |
 Mood disorders | 107/447 | (23.9) | Psychotherapy | 60/106 | (56.6) | 0.3 | −0.1 to 0.8 | 0.169 |
 |  |  | Medication | 52/106 | (49.1) | −2.1 | −16.6 to 12.4 | 0.773 |
 ADHD | 207/447 | (46.3) | Psychotherapy | 146/207 | (70.5) | 0.7 | 0.4 to 1.0 | < 0.001 |
 |  |  | Medication | 168/207 | (81.2) | −5.7 | − 16.1 to 4.6 | 0.275 |
 Other psychiatric disorder | 99/447 | (22.1) | Psychotherapy | 72/99 | (72.7) | 0.6 | 0.1 to 1.0 | 0.011 |
 |  |  | Medication | 46/99 | (46.5) | −6.9 | −20.5 to 6.7 | 0.313 |
Girls | ||||||||
 Any psychiatric disorder | 254 |  | Psychotherapy | 165/242 | (68.2) | 0.4 | 0.2 to 0.7 | 0.002 |
 |  |  | Medication | 114/253 | (45.1) | −1.7 | −10.0 to 6.6 | 0.692 |
 Anxiety disorders | 103/254 | (40.6) | Psychotherapy | 59/102 | (57.8) | 0.6 | 0.2 to 1.0 | 0.007 |
 |  |  | Medication | 36/102 | (35.3) | 7.4 | −5.6 to 20.3 | 0.260 |
 Mood disorders | 88/254 | (34.7) | Psychotherapy | 51/88 | (58.0) | 0.2 | −0.3 to −0.7 | 0.414 |
 |  |  | Medication | 44/88 | (50.0) | 0.4 | −14.7 to 15.4 | 0.960 |
 ADHD | 87/254 | (34.3) | Psychotherapy | 62/87 | (71.3) | 0.7 | 0.3 to 1.2 | 0.002 |
 |  |  | Medication | 66/87 | (75.9) | −9.6 | −25.4 to 6.1 | 0.226 |
 Other psychiatric disorder | 49/254 | (19.3) | Psychotherapy | 36/49 | (73.5) | 0.5 | −0.1 to 1.0 | 0.103 |
 |  |  | Medication | 16/49 | (32.7) | 12.0 | −11.3 to 35.3 | 0.304 |
Boys | ||||||||
 Any psychiatric disorder | 193 |  | Psychotherapy | 134/182 | (73.6) | −0.1 | −0.4 to 0.3 | 0.780 |
 |  |  | Medication | 122/192 | (63.5) | 7.4 | 0.7 to 14.2 | 0.032 |
 Anxiety disorders | 48/193 | (24.9) | Psychotherapy | 36/48 | (75.0) | −0.2 | −0.9 to 0.4 | 0.451 |
 |  |  | Medication | 20/48 | (41.7) | 12.9 | −0.5 to 26.3 | 0.059 |
 Mood disorders | 19/193 | (9.8) | Psychotherapy | 9/18 | (50.0) | −0.9 | −3.2 to 0.4 | 0.141 |
 |  |  | Medication | 8/18 | (44.4) | −9.8 | −34.0 to 14.5 | 0.347 |
 ADHD | 120/193 | (62.2) | Psychotherapy | 84/120 | (70.0) | 0.0 | −0.5 to 0.6 | 0.972 |
 |  |  | Medication | 102/120 | (85.0) | 5.7 | −7.3 to 18.7 | 0.385 |
 Other psychiatric disorder | 50/193 | (25.9) | Psychotherapy | 36/50 | (72.0) | −0.1 | −0.9 to 0.6 | 0.767 |
 |  |  | Medication | 30/50 | (60.0) | −0.9 | −16.7 to 15.0 | 0.913 |